Company intelligence / Profile preview

Nutrilinea

Ownership: Private
Employees: ~53
Development stage: Other

Overview

Nutrilinea was a leading Italian contract manufacturer specializing in food supplements, probiotics, and medical devices. It offered over 500 SKUs for third-party clients globally. In February 2020 it merged with Biofarma to form the Biofarma Group, which has since become a European leader in nutraceutical manufacturing. As of January 2024, all operations are fully integrated under the Biofarma name.

Therapeutic areas: ImmunologyInfectious DiseasesOther
Modalities: Small moleculeProbiotic-based drugsMedical devicesBiologicDevice
Industry: Contract Manufacturing Organization

Partnerships

Partnerships with global pharmaceutical/nutraceutical companies as contract manufacturing clients

Beyond the preview

Go deeper on Nutrilinea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrilinea.

Explore the full profile